Washington -- Artecoll, a new item in the increasingly broad array of permanent and semipermanent nonsurgical wrinkle-reduction options, on Feb. 28 took a big step toward FDA approval.
Comorbidities Women With Hair Loss May Experience
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
The Weekly Roundup: March 20-24
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis
Air Pollution from Wildfire Smoke Can Exacerbate Skin Conditions
2 Clarke Drive Cranbury, NJ 08512